Cassava Sciences Inc (NASDAQ: SAVA) — Healthcare · Share Price, Chart & Market Data
About: Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.66 (-2.35%)
SAVACassava Sciences Inc
Loading watchlist status…
Trade SAVA now
Cassava Sciences Inc share price
SAVA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:01 am GMT+0
SAVA price performance
-2.353%
5D
-1.014%
1M
-20.574%
YTD
4.403%
1Y
SAVA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:01 am GMT+0
SAVA details
SAVA Market Signals